RAC 2.20% $1.78 race oncology ltd

I am guessing that one of the hardest things that would-be...

  1. 3,837 Posts.
    lightbulb Created with Sketch. 652
    I am guessing that one of the hardest things that would-be investors would struggle to believe is that RAC can start, or even complete, in some cases, those trials with just its few million in the bank.

    investors are used to biotech companies raising 20+ million dollars every year or so.

    it is wonderful that RAC can run so many trials so cheaply, but I suspect this claim would have an air of “this is too good to be true” about it for some investors.

    not sure how RAC can solve that problem.
    Last edited by hotcongo: 29/07/20
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.